Brain Cancer | Tumor

CURE’s brain cancer page features the latest cancer news and updates on brain cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in brain cancer.

Lasting Love

October 19th 2019, 12:16am

Article

“Lasting Love” shares a moving and constructive message that may help support youngsters as they navigate a deep loss.

Friday Frontline: Cancer Updates, Research and Education on October 18, 2019

October 18th 2019, 8:00pm

Article

From a chemotherapy drug shortage to Eddie Van Halen revealing a cancer diagnosis, here’s what is making headlines in the cancer space this week.

Providing Personalized Care in Spanish to Patients With Brain and Spine Tumors

October 10th 2019, 6:00pm

Article

After receiving a stage 4 brain cancer diagnosis, a young mother traveled from Mexico to Chicago for treatment.

CURE New Issue Alert: Rare Cancers Special Issue

September 7th 2019, 12:00am

Article

Here’s a look at what’s inside our 2019 Rare Cancers special issue.

Earning Your Legacy: Cancer Has Nothing To Do With It

August 29th 2019, 5:00pm

Podcast

In this episode of the “CURE Talks Cancer” podcast, we spoke with Matt Newman, who was diagnosed with brain cancer at 39, but refuses to let cancer define the legacy he has made.

A Rare Opportunity for Patients With Brain and Spinal Cancers

August 27th 2019, 10:00pm

Article

At free NCI clinics, people with some of the rarest disease get tumor analysis, counseling and expert advice.

When Living with Brain Cancer, Life Doesn't Always Go as Planned

August 14th 2019, 7:00pm

Article

Biden Cancer Initiative Suspends Operations Indefinitely

July 15th 2019, 10:40pm

Article

After two years, the Biden Cancer Initiative has shuttered as former Vice President Joe Biden’s presidential campaign begins in earnest.

Pediatric Neuroblastoma Survivors Face Task Efficiency, Emotional Regulation Impairments

July 9th 2019, 12:00am

Article

Long-term survivors of pediatric neuroblastoma may be at an increased risk for neurocognitive impairment – in particular, due to age at diagnosis and the type of treatment received.

FDA Approves Zirabev, an Avastin Biosimilar, for Five Cancer Types

June 28th 2019, 5:30pm

Article

The FDA has approved Zirabev, a biosimilar to Avastin, for the treatment of five types of cancer: colorectal cancer; non-small cell lung cancer; glioblastoma; metastatic renal cell carcinoma; and persistent, recurrent or metastatic cervical cancer.